The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NRXS · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
THC · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | CODA | NRXS | TDY | THC |
|---|---|---|---|---|
| Moat Score (0–100) | 64 (highest) | 64 (highest) | 64 (highest) | 63 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 48 | 57 | 90 (highest) | 75 |
| Pricing power | 98 | 100 (highest) | 65 | — |
| Returns on capital | 63 (highest) | — | 25 | 49 |
| Balance-sheet safety | 100 (highest) | 55 | 79 | 28 |
| Capital allocation | 9 | 44 | 60 | 100 (highest) |
| 147% above value if growth stopped today | No price data | 161% above value if growth stopped today | 9% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $113M | $72.4M | $30.3B | $20.3B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |